N
NERVGEN PHARMA CORP.
NGENCIK 0001751912NasdaqEmerging GrowthPharmaceutical PreparationsA1CAFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$-44.12M
Total Assets
$23.21M
Equity
—
Shares Out
79.65M
Op. Cash Flow
—
Business
NERVGEN PHARMA CORP. is a foreign private issuer in Pharmaceutical Preparations, headquartered in Canada. Shares trade on Nasdaq under the ticker NGEN.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-44.12M |
| Total assets | $23.21M |
| Total liabilities | $19.73M |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro